NanoViricides, Inc. said that fresh biological rhythm tests and data breakdown have shown that
animals treated with its lead anti-HIV drug candidate, HIVCide-I, demonstrated a substantially
greater reduction in viral load -- number of toxic virus particles ...
(more)